Ignite Creation Date:
2025-12-24 @ 4:42 PM
Ignite Modification Date:
2026-01-17 @ 2:17 PM
Study NCT ID:
NCT06904066
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-03-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malignancy, Hematologic | View |
| None | Neoplasms, Hematologic | View |
| None | Neoplasms, Hematopoietic | View |
| None | Blood Cancer | View |
| None | Hematological Neoplasms | View |
| None | Hematopoietic Malignancies | View |
| None | Dysmyelopoietic Syndromes | View |
| None | Hematopoetic Myelodysplasia | View |
| None | Myeloid Leukemia, Acute | View |
| None | Nonlymphoblastic Leukemia, Acute | View |
| None | Leukemia, Lymphocytic, Acute | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Gene Therapy | View |
| None | T cell immunotherapy | View |
| None | Engineered T cell receptor | View |
| None | Hematologic Malignancies | View |
| None | Tumor-Associated Antigen | View |
| None | Myelodysplastic Syndrome | View |
| None | Neoepitope-specific T cells | View |
| None | T-cell acute lymphoblastic leukemia | View |
| None | Adoptive T Cell Therapy | View |
| None | Chronic Myeloid Leukemia | View |